ISLR/Meflin is a marker of undifferentiated MSCs [71] that has been pointed out as a potential mediator of tumor‐restraining CAFs in pancreatic ductal adenocarcinoma and fibrosis [72], although the underlying mechanisms and potential functions in NSCLC and other cancer types remain undefined. Here, ISLR is linked to pancreatic ductal adenocarcinoma.